Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;37(9):607-12.
doi: 10.1111/j.1745-7270.2005.00082.x.

Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus

Affiliations

Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus

Qing-Jiao Liao et al. Acta Biochim Biophys Sin (Shanghai). 2005 Sep.

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) is the major causative agent for the worldwide outbreak of SARS in 2003. The mechanism by which SARS-CoV causes atypical pneumonia remains unclear. The nuclear factor kappa B (NF-kappaB) is a key transcription factor that activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-kappaB plays an important role in the pathogenesis of lung diseases. In this study, we investigated the possible regulatory interaction between the SARS-CoV nucleocapsid (N) protein and NF-kappaB by luciferase activity assay. Our results showed that the SARS-CoV N protein can significantly activate NF-kappaB only in Vero E6 cells, which are susceptible to SARS-CoV infection, but not in Vero or HeLa cells. This suggests that NF-kappaB activation is cell-specific. Furthermore, NF-kappaB activation in Vero E6 cells expressing the N protein is dose-dependent. Further experiments showed that there is more than one function domain in the N protein responsible for NF-kappaB activation. Our data indicated the possible role of the N protein in the pathogenesis of SARS.

PubMed Disclaimer

References

    1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348: 1967–1976. - PubMed
    1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S et al. Anovel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348: 1953–1966. - PubMed
    1. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300: 1394–1399. - PubMed
    1. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks‐Wilson A, Butterfield YS, Khattra J et al. The genome sequence of the SARS‐associated coronavirus. Science 2003, 300: 1399–1404. - PubMed
    1. He R, Leeson A, Andonov A, Li Y, Bastien N, Cao J, Osiowy C et al. Activation of AP‐1 signal transduction pathway by S ARS coronavirus nucleo‐capsid protein. Biochem Biophys Res Commun 2003, 311: 870–876. - PMC - PubMed

MeSH terms